Mantle Cell Lymphoma (MCL)
Also known as: Mantle Cell Lymphomas / B-cell Mantle Cell Lymphoma / Mantle Cell Lymphoma / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / Mantle-Cell Lymphoma / Lymphoma, Mantle-Cell / MCL / Mantle Cell Lymphoma; Non-Hodgkin Lymphoma / Lymphomas: Non-Hodgkin Mantle Cell / Non-Hodgkin lymphoma, no ICD-O subtype (morphologic abnormality) / Mantle cell lymphoma (morphologic abnormality) / Malignant lymphoma, small cleaved cell, diffuse -RETIRED- / Mantle zone lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphoma (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB11703 | Acalabrutinib | A Bruton tyrosine kinase inhibitor used to treat mantle cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma. |
DB00188 | Bortezomib | A proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies. |
DB00291 | Chlorambucil | A chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas. |
DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |
DB15035 | Zanubrutinib | A kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy. |